CD154–CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis†
Open Access
- 15 July 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 42 (2) , 372-380
- https://doi.org/10.1002/hep.20802
Abstract
The CD154–CD40 interaction is a critical costimulatory pathway modulating the cellular immune response. Moreover, fulminant hepatitis of various etiologies is characterized by a hepatic influx of CD154-expressing T cells and an upregulation of CD40 expression on Kupffer cells and hepatocytes, implicating this pathway in the pathogenesis of fulminant hepatitis. In this study, we used a murine model of fulminant hepatitis induced by concanavalin A (con A) and documented a significant influx of CD154-expressing T cells into the livers of mice treated with con A, in association with markedly increased expression of CD40 restricted mainly to hepatocytes in damaged areas of the liver. Furthermore, con A hepatitis in CD154-deficient mice was significantly attenuated compared with that in wild-type controls and was associated with a decrease in hepatic tumor necrosis factor α (TNF-α) levels and hepatocyte death. We next determined the role of the CD154–CD40 pathway in hepatocyte death in vitro. These in vitro studies demonstrated that TNF-α induces CD40 expression in hepatocytes and that subsequent activation of CD40 results in hepatocyte apoptosis mediated at least in part by enhanced hepatocyte expression of FasL. In conclusion, CD154 stimulation of CD40 plays a central role in hepatocyte death in fulminant hepatitis through direct and indirect pathways that may have direct therapeutic implications in humans. Supplementary material for this article can be found on the HEPATOLOGY website (http://interscience.wiley.com/jpages/0270-9139/suppmat/index.html). (HEPATOLOGY 2005;42:372–380.)Keywords
This publication has 45 references indexed in Scilit:
- CCL3/MIP‐1α is pro‐inflammatory in murine T cell‐mediated hepatitis by recruiting CCR1‐expressing CD4+ T cells to the liverEuropean Journal of Immunology, 2004
- Fulminant hepatic failureGastroenterology Clinics of North America, 2003
- Heterogeneous expression and regulation of CD40 in human hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology, 2003
- Early up‐regulation of chemokine expression in fulminant hepatic failureThe Journal of Pathology, 2003
- Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-γ-dependent mechanismHepatology, 2000
- High Levels of Serum Interleukin‐10 and Tumor Necrosis Factor–α Are Associated with Fatality in Fulminant HepatitisThe Journal of Infectious Diseases, 2000
- Enhanced Expression of CD80 (B7-1), CD86 (B7-2), and CD40 and Their Ligands CD28 and CD154 in Fulminant Hepatic FailureThe American Journal of Pathology, 1999
- CD40 AND CD154 IN CELL-MEDIATED IMMUNITYAnnual Review of Immunology, 1998
- The many roles of CD40 in cell-mediated inflammatory responsesImmunology Today, 1996
- ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILUREThe Lancet, 1988